New Buprenorphine and Naloxone Sublingual Film Indicated for The Treatment of Opioid Dependence

by on February 26, 2019

FDA approved Buprenorphine and Naloxone Sublingual film are available in 8 mg/2 mg and 12 mg/3 mg The prescription is limited to healthcare providers who meet certain qualifying requirements Should be used as part of a complete treatment plan to include counseling and psychosocial supportThis story is related to the following:Medicinal, Pharmaceutical& Nutraceutical Tablets (Source: Industrial Newsroom – Health, Medical and Dental Supplies)

MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.

Previous post:

Next post: